Navigation Links
The Dope on Medical Marijuana: Results of a Survey of Psychiatrists from Psychiatric Times
Date:7/11/2013

NORWALK, Conn., July 11, 2013 /PRNewswire/ -- UBM Medica US announces that Psychiatric Times, the country's best read psychiatric publication, recently conducted a survey of its psychiatrist readers to find out their opinions about whether, when—or under what circumstances—they might prescribe medical marijuana for patients with psychiatric disorders.

Respondents issued radically opposing perspectives, such as:

  • "Marijuana should be legal for all and should not require a prescription."
  • "There is no medical necessity to legalize or prescribe something as addictive or toxic as smoked marijuana."

If results of the survey are any indication—and as the quotes above suggest—there is deep and passionate division of opinion, and considerable confusion surrounding rules that now govern legal prescribing

The results of the survey reflect the opinions of nearly 864 psychiatrists who practice in the US.

About UBM Medica US
Addressing today's healthcare information needs, UBM Medica US, delivers strategic, integrated communications solutions and comprehensive reach -- online, in print, and via custom programs. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers, payers, and patients around the world. Through journals, magazines, websites, online communiti
'/>"/>

SOURCE UBM Medica US
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cellular Biomedicine Group Appoints Director of Medical Research
2. Global Medical Devices Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry
3. Span-America Medical Systems to Release Third Quarter Results on July 31, 2013
4. South Asia Medical Device Market Reports
5. Russia & the CIS Medical Device Market Reports
6. Wesley Medical Center Nominated for Best of 2013 Respiratory Care: Improves Patient Safety By Reducing Opioid-Related Adverse Events to Zero
7. AdvaMed Supports Comprehensive Tax Reform Repeal of the Medical Device Tax Important First Step
8. Medical Disposables Market is Expected to Reach USD 193.89 Billion Globally in 2018: Transparency Market Research
9. Episurf Medical erhält CE-Zertifizierung für sein Knie-Implantat und bereitet baldige Produkteinführung am Markt vor
10. Neusoft Medical Signed Transfer Agreement with Philips to Acquire 25% Equities in Philips-Neusoft Medical Systems Joint Venture
11. Buffalo Area Emergency Medical Service Workers Reject Rural/Metro Contract Concessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Kinex Pharmaceuticals announced today that the first ... Cancer Institute. KX2-361 (KX02), a dual src/pre-tubulin ... potent inhibitory activity against a broad panel of brain ... Temozolomide (T98G), the most widely used chemotherapy for the ... mouse model, KX2-361 consistently clears brain tumors after 4 ...
(Date:12/24/2014)... and FARMINGTON, Conn. , Dec. ... MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific ... significant unmet medical need and commercial potential, today ... placement of 2,050,000 shares of its common stock ... of its common stock.  Funds under the management ...
(Date:12/24/2014)... Dec. 23, 2014 ResMed (NYSE: RMD ... action against Chinese medical device manufacturer BMC Medical Co., Ltd. ... that BMC,s masks listed below infringe ResMed,s patents, and entered ... masks in the United States : ... mask , Willow nasal pillows mask , iVolve ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2
... Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing ... Chief Technology Officer, will present at the Sidoti & ... on Thursday, November 10, 2011 at 1:20 p.m. ET. ... New York Hotel in New York City. ...
... Nov. 7, 2011 Reportlinker.com ... research report is available in ... Implantable Cardioverter Defibrillators and Cardiac ... Analysis, Competitive Landscape and Market ...
Cached Medicine Technology:Abaxis, Inc. to Present at Sidoti & Company's New York II Emerging Growth Institutional Investor Forum 2Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 13Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 14Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 15Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 16
(Date:12/25/2014)... 25, 2014 (HealthDay News) -- The risk of burns ... so you need to be extra cautious, an expert ... see a significant increase in patients coming in with ... Suffolk County Volunteer Firefighters Burn Center of Stony Brook ... be full of joy, but if not careful, could ...
(Date:12/25/2014)... Among early stage breast cancer patients who undergo chemotherapy ... will eventually develop leukemia as a result of their ... from a review of more than 20,000 breast cancer ... that the risk for developing treatment-related leukemia, though low, ... "The frequency of bone marrow cancers such as leukemia ...
(Date:12/25/2014)... tries its best to translate the experience of dress ... introduced its new collection of 2015 prom dresses, and ... prom outfits are guaranteed to contain the perfect designs ... designed for 2015. Anyone who wants to buy ... before Jan. 26, 2015, the deadline of the promotion. ...
(Date:12/25/2014)... December 25, 2014 “ SmileStix ” was ... features the latest and coolest mobile applications on the iOS, ... and host of NewsWatch, conducted the app review and shared ... create personal stickers. , The old saying goes, “A picture ... of words that can describe a single image, because each ...
(Date:12/25/2014)... Newton, North Carolina (PRWEB) December 25, 2014 ... a North Carolina Retirement Community, recently showed their ... and girls of the Catawba County Parenting Network- ... meal, the 10 children gathered around the largest ... community to open presents purchased by residents of ...
Breaking Medicine News(10 mins):Health News:Don't Let Burns Mar Your Holidays 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Angelweddingdress 2015 Prom Dresses Online Now 2Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:Retirement Community Residents Make Impact During Holiday Season 2
... ATLANTA - Two drugs approved for use as second line ... frontline therapy for newly diagnosed patients in two clinical trials, ... M. D. Anderson Cancer Center report at the 49th annual ... All patients in both trials have a complete cytogenetic response ...
... PORTLAND, Ore. Gleevec, the targeted cancer pill that has ... with a dire leukemia, as well as preventing disease progression ... , Data at this weekends meeting continues to ... so many, many patients facing cancer, said Brian Druker, M.D., ...
... ALTO, Calif., Dec. 8 Telik, Inc.,(Nasdaq: ... Phase 1,dose-escalation study of TELINTRA(R) (ezatiostat HCl) Tablets ... Phase 2,clinical trials. The data were reported at ... Hematology in Atlanta., The objectives of the ...
... Dec. 8 Data that shed new light ... total,hip replacement, chronic immune thrombocytopenic purpura, and venous,thrombosis ... presented at the 49th Annual Meeting of the ... conference will reveal this new research,on Saturday, December ...
... between mitochondria, memory and socialization , FRIDAY, Dec. ... deficiencies in mitochondria (the source of energy in ... and spatial memory, Japanese researchers report. , The ... between mitochondrial malfunction and mental illness in humans, ...
... a reminder that we must remain vigilant,in protecting women,s ... dedicated health care professionals who provide that care, ... Vicki Saporta, President and CEO of the National Abortion,Federation, ... MD, in Albuquerque,NM:, As the professional association of ...
Cached Medicine News:Health News:Dasatinib, Nilotinib show strong early results as frontline therapy for chronic myelogenous leukemia 2Health News:Dasatinib, Nilotinib show strong early results as frontline therapy for chronic myelogenous leukemia 3Health News:Gleevec, the targeted cancer pill, delivers more good news to patients 2Health News:Telik Reports Positive Results From Phase 1 Dose-Escalation Study of TELINTRA Tablets in Myelodysplastic Syndrome 2Health News:Telik Reports Positive Results From Phase 1 Dose-Escalation Study of TELINTRA Tablets in Myelodysplastic Syndrome 3Health News:Research Highlights New Approaches to Management of Blood Clotting and Bleeding Disorders 2Health News:Research Highlights New Approaches to Management of Blood Clotting and Bleeding Disorders 3Health News:Research Highlights New Approaches to Management of Blood Clotting and Bleeding Disorders 4Health News:Research Highlights New Approaches to Management of Blood Clotting and Bleeding Disorders 5Health News:Research Highlights New Approaches to Management of Blood Clotting and Bleeding Disorders 6
... helps you deliver unmatched performance through patient-focused ... the most complete anesthesia solution developed, putting ... - at your fingertips., ,The Aisys ... legacy of anesthesia delivery and patient monitoring ...
... Mesh LP is a super-light polypropylene mesh ... body reaction is reduced considerably. Optilene Mesh ... all open hernia repair procedures. It perfectly ... flexibility Optilene Mesh LP adapts to the ...
... Mesh Elastic is a lightweight and large pore ... mesh is able to adapt to all movements ... honeycomb like structure with the large pores enables ... The mesh is ideal for incisional hernia repair ...
... is a lightweight polypropylene mesh which ... reduced,foreign body reaction. The softer, microfilament ... perfectly conforms to,anatomical structures. Due to ... adapts to the movements of the ...
Medicine Products: